Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Update Il y a 4 ans
Reference: NCT01323946

Woman and Man

Extract

The objective of the study is to evaluate the immunogenicity and safety of prime-boost vaccination schedule of GSK Biologicals' investigational vaccine GSK1562902A.


Inclusion criteria

  • Influenza

Links